ovarian cancerHER2-expressing diseasePROCBevacizumabTrastuzumab deruxtecanadavosertibmirvetuximab soravtansineplatinum-based therapyhyperthermic intraperitoneal chemotherapy
…o demonstrate benefit in phase III trials.In platinum-resistant ovarian cancer (PROC), platinum rechallenge retains activity in selected patie…